Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tumor Lysis Syndrome

"Tumor Lysis Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.


This graph shows the total number of publications written about "Tumor Lysis Syndrome" by people in Harvard Catalyst Profiles by year, and whether "Tumor Lysis Syndrome" was a major or minor topic of these publication.
Bar chart showing 21 publications over 15 distinct years, with a maximum of 3 publications in 2015 and 2017
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.